Loading…
Paxlovid and Lagevrio are oral antiviral medications that can be prescribed by a doctor to treat COVID-19. Did you take Paxlovid or Lagevrio for your most recent COVID-19 infection?
Asked of: WHENCOVID1=1 or WHENCOVID2 = 1
Took Paxlovid or Lagevrio for recent COVID-19 infection · Asked in 5 waves, 2023 · 61,924 responses · weighted estimates computed from individual responses
Periods loaded: week59, week60, week61, week62, week63. Version of COVIDTRT_YNDK first asked in week59: wording, reference period, answer options, or (for a checkbox) the option it names or whether the question offers a 'none of these' box differ from census_pulse:covidtrt_yndk.
Shares of people who gave an answer. Each column is one wave, evenly spaced rather than to scale in time; hover for exact shares.
Shares of people who gave an answer. A group’s column is left blank in waves where its effective sample is under 50; hover for exact shares.
| Group | Yes | No | n | MoE | |
|---|---|---|---|---|---|
| All respondents | 19% | 81% | 13799 | ±2 | |
| AK | 21% | 79% | 205 | ±9 | |
| AL |
| Poll | Field dates | Mode | Respondents | Responses |
|---|---|---|---|---|
| Household Pulse Survey, Week 63 (2023-10-18 to 2023-10-30) Source variable COVIDTRT_YNDK. Universe: WHENCOVID1=1 or WHENCOVID2 = 1. | 2023-10-18 to 2023-10-30 | web | 79,371 | 13,799 |
| Household Pulse Survey, Week 62 (2023-09-20 to 2023-10-02) Source variable COVIDTRT_YNDK. Universe: WHENCOVID1=1 or WHENCOVID2 = 1. | 2023-09-20 to 2023-10-02 | web | 72,839 | 12,777 |
| Household Pulse Survey, Week 61 (2023-08-23 to 2023-09-04) Source variable COVIDTRT_YNDK. Universe: WHENCOVID1=1 or WHENCOVID2 = 1. | 2023-08-23 to 2023-09-04 | web | 68,454 | 11,206 |
| Household Pulse Survey, Week 60 (2023-07-26 to 2023-08-07) Source variable COVIDTRT_YNDK. Universe: WHENCOVID1=1 or WHENCOVID2 = 1. | 2023-07-26 to 2023-08-07 | web | 68,830 | 11,970 |
| Household Pulse Survey, Week 59 (2023-06-28 to 2023-07-10) Source variable COVIDTRT_YNDK. Universe: WHENCOVID1=1 or WHENCOVID2 = 1. | 2023-06-28 to 2023-07-10 | web | 63,802 | 12,172 |
| 25% |
| 75% |
| 176 |
| ±10 |
| AR | 20% | 80% | 157 | ±11 |
| AZ | 16% | 84% | 306 | ±8 |
| CA | 20% | 80% | 1091 | ±6 |
| CO | 15% | 85% | 378 | ±7 |
| CT | 18% | 82% | 260 | ±8 |
| DC | 19% | 81% | 253 | ±12 |
| DE | 22% | 78% | 144 | ±10 |
| FL | 19% | 81% | 413 | ±9 |
| GA | 17% | 83% | 297 | ±8 |
| HI | 27% | 73% | 154 | ±12 |
| IA | 14% | 86% | 184 | ±11 |
| ID | 9% | 91% | 265 | ±11 |
| IL | 17% | 83% | 292 | ±8 |
| IN | 14% | 86% | 216 | ±9 |
| KS | 20% | 80% | 242 | ±10 |
| KY | 16% | 84% | 201 | ±9 |
| LA | 16% | 84% | 152 | ±11 |
| MA | 22% | 78% | 400 | ±7 |
| MD | 20% | 80% | 340 | ±8 |
| ME | 20% | 80% | 200 | ±9 |
| MI | 20% | 80% | 357 | ±7 |
| MN | 24% | 76% | 313 | ±8 |
| MO | 18% | 82% | 231 | ±9 |
| MS | 18% | 82% | 144 | ±13 |
| MT | 18% | 82% | 169 | ±10 |
| NC | 23% | 77% | 266 | ±8 |
| ND † | 17% | 83% | 87 | ±15 |
| NE | 15% | 85% | 189 | ±11 |
| NH | 12% | 88% | 216 | ±9 |
| NJ | 19% | 81% | 256 | ±8 |
| NM | 24% | 76% | 254 | ±10 |
| NV | 21% | 79% | 189 | ±11 |
| NY | 21% | 79% | 254 | ±9 |
| OH | 14% | 86% | 209 | ±10 |
| OK | 19% | 81% | 167 | ±10 |
| OR | 19% | 81% | 415 | ±8 |
| PA | 19% | 81% | 371 | ±8 |
| RI | 22% | 78% | 146 | ±11 |
| SC | 14% | 86% | 212 | ±9 |
| SD | 20% | 80% | 127 | ±12 |
| TN | 19% | 81% | 209 | ±10 |
| TX | 23% | 77% | 576 | ±8 |
| UT | 12% | 88% | 377 | ±9 |
| VA | 17% | 83% | 386 | ±8 |
| VT | 15% | 85% | 206 | ±11 |
| WA | 14% | 86% | 691 | ±8 |
| WI | 17% | 83% | 222 | ±9 |
| WV | 16% | 84% | 145 | ±12 |
| WY | 15% | 85% | 89 | ±13 |
Household Pulse Survey, Week 63 (2023-10-18 to 2023-10-30) · US adults 18+ living in housing units (50 states and DC). Shares of people who gave an answer. n is unweighted; ± is the 95% margin of error at 50% from the weighted effective sample. Groups with an effective sample under 50 are grayed; under 20, hidden.